Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,479 Cr
up ₹116 Cr vs May 2024
- Stocks held
- 27
- up 1 vs May 2024
- Top 10 weight
- 68.1%
- of the portfolio in its ten largest
- Cash & debt
- 1.9%
- cash, money market and debt
- Moves this month
- 2 in · 1 out
- added to 10, trimmed 6
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In June 2024 it disclosed 27 stocks worth ₹2,479 Cr, up ₹116 Cr from May 2024. Its largest positions were Sun Pharmaceutical Industries Limited (12.5%), Suven Pharmaceuticals Limited (9.4%), Cipla Limited (8.3%); the ten largest together made up 68.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 68.8% of its equity. Cash and debt stood at 1.9%. Compared with May 2024 the fund entered 2 new stocks and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
11%
Holds more stocks than 11% of peers
Cash
28%
Holds more cash than 28% of peers
What these mean: concentration · cash
Holdings in June 2024
Download CSVEvery line the fund disclosed, with the change against May 2024. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 12.50% | down 0.09 pts | ₹310 Cr | up ₹12.4 Cr | Added |
| Suven Pharmaceuticals Limited | 9.38% | up 1.83 pts | ₹233 Cr | up ₹54 Cr | Added |
| Cipla Limited | 8.28% | down 0.21 pts | ₹205 Cr | up ₹4.7 Cr | Added |
| IPCA Laboratories Limited | 7.31% | down 0.51 pts | ₹181 Cr | down ₹3.6 Cr | Trimmed |
| Lupin Limited | 7.14% | down 0.17 pts | ₹177 Cr | up ₹4.2 Cr | Added |
| Globus Medical Inc | 5.37% | down 0.14 pts | ₹133 Cr | up ₹2.9 Cr | Added |
| Alembic Pharmaceuticals Limited | 5.03% | down 0.53 pts | ₹125 Cr | down ₹6.6 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 4.65% | up 0.05 pts | ₹115 Cr | up ₹6.5 Cr | Added |
| Zydus Lifesciences Limited | 4.49% | up 0.10 pts | ₹111 Cr | up ₹7.7 Cr | Added |
| Concord Biotech Limited | 3.90% | up 0.03 pts | ₹96.7 Cr | up ₹5.3 Cr | Added |
| Procter & Gamble Health Limited | 3.23% | up 0.08 pts | ₹80.1 Cr | up ₹5.5 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.08% | down 0.43 pts | ₹76.3 Cr | down ₹6.6 Cr | Trimmed |
| Alkem Laboratories Limited | 2.93% | down 0.03 pts | ₹72.7 Cr | up ₹2.6 Cr | Added |
| Kovai Medical Center and Hospital Limited | 2.86% | down 0.08 pts | ₹70.8 Cr | up ₹1.5 Cr | Added |
| Intuitive Surgical Inc | 2.81% | up 0.15 pts | ₹69.7 Cr | up ₹6.8 Cr | Added |
| Indoco Remedies Limited | 2.74% | up 0.08 pts | ₹67.9 Cr | up ₹5.1 Cr | Added |
| Cash, TREPS & receivables | 1.94% | up 0.67 pts | ₹48.2 Cr | up ₹18 Cr | Added |
| Illumina Inc | 1.84% | down 0.08 pts | ₹45.6 Cr | up ₹13 L | Held |
| ICICI Lombard General Insurance Company Limited | 1.74% | up 0.13 pts | ₹43.2 Cr | up ₹5 Cr | Added |
| Unichem Laboratories Limited | 1.58% | down 0.11 pts | ₹39.1 Cr | down ₹79 L | Trimmed |
| Aarti Drugs Limited | 1.50% | up 0.01 pts | ₹37.2 Cr | up ₹2 Cr | Added |
| Narayana Hrudayalaya Limited | 1.45% | down 0.05 pts | ₹35.9 Cr | up ₹46 L | Added |
| Abbott Laboratories | 1.11% | down 0.03 pts | ₹27.4 Cr | up ₹50 L | Added |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 0.86% | down 0.02 pts | ₹21.3 Cr | up ₹63 L | Added |
| Gland Pharma Limited | 0.73% | up 0.73 pts | ₹18.1 Cr | up ₹18.1 Cr | New |
| MedPlus Health Services Limited | 0.53% | down 0.07 pts | ₹13.1 Cr | down ₹94 L | Trimmed |
| Jupiter Life Line Hospitals Limited | 0.51% | up 0.02 pts | ₹12.5 Cr | up ₹1.2 Cr | Added |
| Pfizer Limited | 0.46% | down 0.03 pts | ₹11.5 Cr | down ₹21 L | Trimmed |
| Grail Inc | 0.05% | up 0.05 pts | ₹1.1 Cr | up ₹1.1 Cr | New |
What changed, May 2024 to Jun 2024
New New positions (2)
- Gland Pharma Limited0.7% · ₹18.1 Cr
- Grail Inc<0.1% · ₹1.1 Cr
Exited Exited (1)
- Taro Pharmaceutical Industries Limitedwas 1.4% · ₹31.9 Cr
Added Biggest additions
- Suven Pharmaceuticals Limitedup ₹54 Cr (+1.83% pts)
- Sun Pharmaceutical Industries Limitedup ₹12.4 Cr (−0.09% pts)
- Zydus Lifesciences Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2024, the weight rose most in Pharmaceuticals & Biotechnology (+0.3 pts) and Insurance (+0.1 pts), and fell most in Healthcare Services (−0.4 pts).
- Pharmaceuticals & Biotechnology68.5% → 68.8%+0.3 pts
- Insurance1.7% → 1.8%+0.1 pts
- Healthcare Services15.3% → 14.8%−0.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2021 | Jun 2023 | Dec 2023 | Mar 2024 | May 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 62.2% | 71.1% | 71.8% | 71.3% | 68.5% | 68.8% |
| Healthcare Services | 22.2% | 13.6% | 12.4% | 13.9% | 15.3% | 14.8% |
| Healthcare Equipment & Supplies | 6.0% | 6.4% | 7.6% | 7.1% | 8.3% | 8.4% |
| Pharmaceuticals | 6.8% | 5.4% | 5.7% | 5.3% | 5.6% | 5.6% |
| Insurance | 2.8% | 2.4% | 1.7% | 1.8% | 1.7% | 1.8% |
| Retailing | — | 1.1% | 0.7% | 0.6% | 0.6% | 0.5% |
Allocation in Jun 2024change vs May 2024
- Pharmaceuticals & Biotechnology (13)68.8%▲ 0.3 pts
- Healthcare Services (7)14.8%▼ 0.4 pts
- Healthcare Equipment & Supplies (2)8.4%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jun 2024
1.9%
▲ 0.7 pts vs May 2024
- Cash alone
- 1.9%
- cash and net receivables
- A year earlier
- 0.9%
- Jun 2023 · now ▲ 1.0 pts
- Last 12 months
- 0.9% – 3.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.